Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 638 publications
Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.
Journal: Kidney medicine
Published: November 10, 2025
RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1 (PH1).
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 03, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary Hyperoxaluria.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 22, 2025
Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight-Patient Case Series in the Pre-siRNA Era.
Journal: Pediatric transplantation
Published: September 20, 2025
LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1.
Journal: Clinical and translational medicine
Published: July 18, 2025
Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.
Journal: Seminars in nephrology
Published: July 15, 2025
Primary hyperoxaluria: insights into its clinical presentation, genetic mutations, and transplantation outcomes in a pediatric population in a tertiary care center.
Journal: Orphanet journal of rare diseases
Published: June 25, 2025
Administration of lumasiran in a child with infantile oxalosis undergoing chronic peritoneal dialysis: A case report
Journal: Nephrologie & therapeutique
Published: June 11, 2025
Population Pharmacokinetic and Pharmacodynamic Modelling and Simulation for Nedosiran Clinical Development and Dose Guidance in Pediatric Patients with Primary Hyperoxaluria Type 1.
Journal: Clinical pharmacokinetics
Published: June 05, 2025
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 14, 2025
Genetic Correction of the Most Common Mutation Causing Primary Hyperoxaluria Restores Enzyme Localization and Oxalate Metabolism.
Journal: Journal of inherited metabolic disease
Published: April 28, 2025
Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1.
Journal: The Journal of biological chemistry
Published: April 14, 2025
Last Updated: 01/07/2026